Inflammation, cerebral vasospasm, and evolving theories of delayed cerebral ischemia

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Carr, Kevin R ^a   Zuckerman, Scott L ^b   Mocco, J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1;

BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN VASOSPASM; CALCIUM CELL LEVEL; DELAYED CEREBRAL ISCHEMIA; DIAGNOSTIC PROCEDURE; DIAPEDESIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; ENCEPHALITIS; HUMAN; INFLAMMATORY CELL; LEUKOCYTOSIS; MORBIDITY; NONHUMAN; PARAMETERS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84884267499     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/506584     Document Type: Review

References (152)

1. Velat G. J., Kimball M. M., Mocco J, Hoh B. L., Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurgery 2011 76 5 446 454 2-s2.0-82955242474 10.1016/j.wneu.2011.02.030
2. Mayberg M. R., Batjer H. H., Dacey R., Diringer M., Haley E. C., Heros R. C., Sternau L. L., Torner J., Adams H. P. Jr., Feinberg W., Thies W., Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1994 90 5 2592 2605 2-s2.0-0027998061
3. Kassell N. F., Sasaki T., Colohan A. R. T., Nazar G., Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985 16 4 562 572 2-s2.0-0021873601
4. Weir B., Macdonald R. L., Stoodley M., Etiology of cerebral vasospasm. Acta Neurochirurgica, Supplement 1999 1999 72 27 46 2-s2.0-0032615821
5. Haley E. C. Jr., Kassell N. F., Torner J. C., The international cooperative study on the timing of aneurysm surgery: the North American experience. Stroke 1992 23 2 205 214 2-s2.0-0026549815
6. Mayberg M. R., Batjer H. H., Dacey R., Diringer M., Haley E. C., Heros R. C., Sternau L. L., Torner J., Adams H. P. Jr., Feinberg W., Thies W., Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994 25 11 2315 2328 2-s2.0-0028037075
7. Bavbek M., Polin R., Kwan A.-L., Arthur A. S., Kassell N. F., Lee K. S., Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998 29 9 1930 1935 2-s2.0-0031658053
8. Thai Q.-A., Oshiro E. M., Tamargo R. J., Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 1999 30 1 140 147 2-s2.0-0032908502
9. Fabender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Wendel-Wellner M., Ragoschke A., Kuehl S., Brunner J., Schürer L., Schmiedeck P., Hennerici M., Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000 31 12 2971 2975 2-s2.0-0033661938
10. Clatterbuck R. E., Gailloud P., Ogata L., Gebremariam A., Dietsch G. N., Murphy K. J., Tamargo R. J., Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. Journal of Neurosurgery 2003 99 2 376 382 2-s2.0-0042345024
11. Dumont A. S., Dumont R. J., Chow M. M., Lin C.-L., Calisaneller T., Ley K. F., Kassell N. F., Lee K. S., Barrow D. L., Macdonald R. L., Hoh B. L., Ogilvy C. S., Lawton M. T., Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003 53 1 123 135 2-s2.0-0038725119
12. McGirt M. J., Mavropoulos J. C., McGirt L. Y., Alexander M. J., Friedman A. H., Laskowitz D. T., Lynch J. R., Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2003 98 6 1222 1226 2-s2.0-0037850709
13. Ulbrich H., Eriksson E. E., Lindbom L., Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends in Pharmacological Sciences 2003 24 12 640 647 2-s2.0-0344256483 10.1016/j.tips.2003.10.004
14. Frazier J. L., Pradilla G., Wang P. P., Tamargo R. J., Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 1 93 98 2-s2.0-3042567010
15. Pradilla G., Wang P. P., Legnani F. G., Ogata L., Dietsch G. N., Tamargo R. J., Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. Journal of Neurosurgery 2004 101 1 88 92 2-s2.0-3042615226
16. Keiper T., Santoso S., Nawroth P. P., Orlova V., Chavakis T., The role of junctional adhesion molecules in cell-cell interactions. Histology and Histopathology 2005 20 1 197 203 2-s2.0-11144260996
17. Pradilla G., Thai Q.-A., Legnani F. G., Clatterbuck R. E., Gailloud P., Murphy K. P., Tamargo R. J., Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. Neurosurgery 2005 57 1, supplement S-184 S-189 2-s2.0-21744459403 10.1227/01.NEU.0000163604.52273.28
18. Gallia G. L., Tamargo R. J., Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurological Research 2006 28 7 750 758 2-s2.0-33750442202 10.1179/016164106X152025
19. Recinos P. F., Pradilla G., Thai Q.-A., Perez M., Hdeib A. M., Tamargo R. J., Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood. Surgical Neurology 2006 66 5 463 469 2-s2.0-33750475590 10.1016/j.surneu.2006.04.010
20. Echigo R., Shimohata N., Karatsu K., Yano F., Kayasuga-Kariya Y., Fujisawa A., Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. Journal of Translational Medicine 2012 10 1 80
21. Takeuchi H., Tanabe M., Okamoto H., Yamazaki M., Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurological Research 1999 21 5 513 516 2-s2.0-0032777134
22. Jadhav V. D., Jabre A., Lee T. J.-F., Effect of phospholipase C blockade on cerebral vasospasm. Cerebrovascular Diseases 2008 25 4 362 365 2-s2.0-42349092444 10.1159/000118383
23. Pradilla G., Garzon-Muvdi T., Ruzevick J. J., Bender M., Edwards L., Momin E. N., Thompson R. C., Tamargo R. J., Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage. Neurosurgery 2012 70 747 756 2-s2.0-80052557128 10.1227/NEU. 0b013e3182363c2f
24. Vellimana A. K., Milner E., Azad T. D., Harries M. D., Zhou M.-L., Gidday J. M., Han B. H., Zipfel G. J., Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 2011 42 3 776 782 2-s2.0-79952072187 10.1161/STROKEAHA.110. 607200
25. Pluta R. M., Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005 105 1 23 56 2-s2.0-11044230424 10.1016/j.pharmthera.2004.10.002
26. Suhardja A., Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Nature Clinical Practice Cardiovascular Medicine 2004 1 2 110 116 2-s2.0-20444459839 10.1038/ncpcardio0046
27. Momin E. N., Schwab K. E., Chaichana K. L., Miller-Lotan R., Levy A. P., Tamargo R. J., Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage. Neurosurgery 2009 65 5 937 945 2-s2.0-70350291828 10.1227/01.NEU.0000356974. 14230.B8
28. Capampangan D. J., Wellik K. E., Aguilar M. I., Demaerschalk B. M., Wingerchuk D. M., Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage? Neurologist 2008 14 6 395 398 2-s2.0-57749105227 10.1097/NRL.0b013e31818a0f29
29. Vorkapic P., Bevan J. A., Bevan R. D., Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurgical Review 1991 14 3 215 219 2-s2.0-0025868116
30. Weir B., Grace M., Hansen J., Rothberg C., Time course of vasospasm in man. Journal of Neurosurgery 1978 48 2 173 178 2-s2.0-0017836563
31. Mills J. N., Mehta V., Russin J., Amar A. P., Rajamohan A., Mack W. J., Advanced imaging modalities in the detection of cerebral vasospasm. Neurology Research International 2013 2013 15 415960 10.1155/2013/415960
32. Ecker A., Riemenschneider P. A., Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. Journal of Neurosurgery 1951 8 6 660 667 2-s2.0-0001337612
33. Perez-Arjona E. A., Delproposto Z., Sehgal V., Fessler R. D., New techniques in cerebral imaging. Neurological Research 2002 24 supplement 1 S17 S26 2-s2.0-0036280047
34. Janjua N., Mayer S. A., Cerebral vasospasm after subarachnoid hemorrhage. Current Opinion in Critical Care 2003 9 2 113 119 2-s2.0-0037384077 10.1097/00075198-200304000-00006
35. Greenberg E. D., Gold R., Reichman M., John M., Ivanidze J., Edwards A. M., Johnson C. E., Comunale J. P., Sanelli P., Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis. American Journal of Neuroradiology 2010 31 10 1853 1860 2-s2.0-78649682504 10.3174/ajnr.A2246
36. Dehdashti A. R., Rufenacht D. A., Delavelle J., Reverdin A., De Tribolet N., Therapeutic decision and management of aneurysmal subarachnoid haemorrhage based on computed tomographic angiography. British Journal of Neurosurgery 2003 17 1 46 53 2-s2.0-0037691817 10.1080/026889031000093735
37. Anderson G. B., Findlay J. M., Steinke D. E., Ashforth R., Experience with computed tomographic angiography for the detection of intracranial aneurysms in the setting of acute subarachnoid hemorrhage. Neurosurgery 1997 41 3 522 528 2-s2.0-0030882021 10.1097/00006123-199709000-00003
38. Chen F., Wang X., Wu B., Neuroimaging research on cerebrovascular spasm and its current progress. Acta Neurochirurgica. Supplement 2011 110 2 233 237 2-s2.0-79952276414
39. Tamatani S., Sasaki O., Takeuchi S., Fujii Y., Koike T., Tanaka R., Detection of delayed cerebral vasospasm, after rupture of intracranial aneurysms, by magnetic resonance angiography. Neurosurgery 1997 40 4 748 754 2-s2.0-0030946291 10.1097/00006123-199704000-00017
40. Grandin C. B., Cosnard G., Hammer F., Duprez T. P., Stroobandt G., Mathurin P., Vasospasm after subarachnoid hemorrhage: diagnosis with MR angiography. American Journal of Neuroradiology 2000 21 9 1611 1617 2-s2.0-0033776701
41. Dalessandri K., St. John J. N., Carson S. N., Correction and monitoring of postoperative cerebral vasospasm. Angiology 1981 32 3 212 216 2-s2.0-0019425803
42. Aaslid R., Markwalder T. M., Nornes H., Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. Journal of Neurosurgery 1982 57 6 769 774 2-s2.0-0020394689
43. Suarez J. I., Qureshi A. I., Yahia A. B., Parekh P. D., Tamargo R. J., Williams M. A., Ulatowski J. A., Hanley D. F., Razumovsky A. Y., Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Critical Care Medicine 2002 30 6 1348 1355 2-s2.0-0036272993
44. Burch C. M., Wozniak M. A., Sloan M. A., Rothman M. I., Rigamonti D., Permutt T., Numaguchi Y., Detection of intracranial internal carotid artery and middle cerebral artery vasospasm following subarachnoid hemorrhage. Journal of Neuroimaging 1996 6 1 8 15 2-s2.0-0030039382
45. Wozniak M. A., Sloan M. A., Rothman M. I., Burch C. M., Rigamonti D., Permutt T., Numaguchi Y., Detection of vasospasm by transcranial Doppler sonography: the challenges of the anterior and posterior cerebral arteries. Journal of Neuroimaging 1996 6 2 87 93 2-s2.0-0029986360
46. Lindegaard K. F., Nornes H., Bakke S. J., Sorteberg W., Nakstad P., Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochirurgica, Supplement 1988 42 81 84 2-s2.0-0023706485
47. Okada Y., Shima T., Nishida M., Yamane K., Hatayama T., Yamanaka C., Yoshida A., Comparison of transcranial doppler investigation of aneurysmal vasospasm with digital subtraction angiographic and clinical findings. Neurosurgery 1999 45 3 443 450 2-s2.0-0032878782 10.1097/00006123-199909000- 00005
48. White H., Venkatesh B., Applications of transcranial Doppler in the ICU: a review. Intensive Care Medicine 2006 32 7 981 994 2-s2.0-33745491672 10.1007/s00134-006-0173-y
49. Lysakowski C., Walder B., Costanza M. C., Tramèr M. R., Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 2001 32 10 2292 2298 2-s2.0-0034793576
50. Sloan M. A., Haley E. C. Jr., Kassel N. F., Henry M. L., Stewart S. R., Beskin R. R., Sevilla E. A., Torner J. C., Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 1989 39 11 1514 1518 2-s2.0-0024853614
51. Liu-DeRyke X., Rhoney D. H., Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management. Pharmacotherapy 2006 26 2 182 203 2-s2.0-32044458425 10.1592/phco.26.2.182
52. Walton J. N., The prognosis and management of subarachnoid haemorrhage. Canadian Medical Association Journal 1955 72 3 165 175
53. Rousseaux P., Scherpereel B., Bernard M. H., Graftieaux J. P., Guyot J. F., Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surgical Neurology 1980 14 6 459 465 2-s2.0-0019158236
54. Spallone A., Acqui M., Pastore F. S., Guidetti B., Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surgical Neurology 1987 27 3 253 258 2-s2.0-0023138063
55. Pradilla G., Chaichana K. L., Hoang S., Huang J., Tamargo R. J., Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010 21 2 365 379 2-s2.0-77951039949 10.1016/j.nec.2009.10.008
56. Chaichana K. L., Pradilla G., Huang J., Tamargo R. J., Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurgery 2010 73 1 22 41 2-s2.0-77953246444 10.1016/j.surneu.2009.05.027
57. Edwards D. H., Byrne J. V., Griffith T. M., The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. Journal of Neurosurgery 1992 76 5 830 837 2-s2.0-0026590707
58. Agil A., Fuller C. J., Jialal I., Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction. Clinical Chemistry 1995 41 2 220 225 2-s2.0-0028944891
59. Griffith T. M., Edwards D. H., Lewis M. J., Newby A. C., Henderson A. H., The nature of endothelium-derived vascular relaxant factor. Nature 1984 308 5960 645 647 2-s2.0-0021223879
60. Gutteridge J. M. C., Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry 1995 41 12 1819 1828 2-s2.0-0028792111
61. Kolias A. G., Sen J., Belli A., Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. Journal of Neuroscience Research 2009 87 1 1 11 2-s2.0-63049113042 10.1002/jnr.21823
62. Ayer R. E., Zhang J. H., Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochirurgica, Supplementum 2008 104 33 41 2-s2.0-44449172082 10.1007/978-3-211-75718-5-7
63. Maeda Y., Hirano K., Nishimura J., Sasaki T., Kanaide H., Endothelial dysfunction and altered bradykinin response due to oxidative stress induced by serum deprivation in the bovine cerebral artery. European Journal of Pharmacology 2004 491 1 53 60 2-s2.0-16544395129 10.1016/j.ejphar.2004.03.019
64. Provencio J. J., Vora N., Subarachnoid hemorrhage and inflammation: bench to bedside and back. Seminars in Neurology 2005 25 4 435 444 2-s2.0-33644844082 10.1055/s-2005-923537
65. Chaichana K. L., Levy A. P., Miller-Lotan R., Shakur S., Tamargo R. J., Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 2007 38 12 3266 3271 2-s2.0-36448932807 10.1161/STROKEAHA.107.490003
66. Lin C.-L., Kwan A.-L., Dumont A. S., Su Y.-F., Kassell N. F., Wang C.-J., Wu S.-C., Kuo C.-L., Huang C.-S., Jeng A. Y., Liu C.-S., Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303. Journal of Neurosurgery 2007 106 3 442 448 2-s2.0-33847658409 10.3171/jns.2007.106.3.442
67. Lin C.-L., Dumont A. S., Calisaneller T., Kwan A.-L., Hwong S.-L., Lee K. S., Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surgical Neurology 2005 64 3 201 206 2-s2.0-23744502674 10.1016/j.surneu.2005.04.038
68. Jdrzejowska-Szypułka H., Larysz-Brysz M., Kukla M., Śnietura M., Lewin-Kowalik J., Neutralization of interleukin-1 β reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats. Current Neurovascular Research 2009 6 2 95 103 2-s2.0-65749100969 10.2174/156720209788185669
69. Chen G., Wu J., Sun C., Qi M., Hang C., Gong Y., Han X., Shi J., Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Research 2008 1214 136 144 2-s2.0-44249114782 10.1016/j.brainres.2008.03.085
70. Bowman G., Bonneau R. H., Chinchilli V. M., Tracey K. J., Cockroft K. M., A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm. Neurocritical Care 2006 5 3 222 229 2-s2.0-33846961135 10.1385/NCC:5:3:222
71. Yatsushige H., Yamaguchi M., Zhou C., Calvert J. W., Zhang J. H., Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005 36 7 1538 1543 2-s2.0-22044455107 10.1161/01.STR. 0000170713.22011.c8
72. Muller W. A., Mechanisms of leukocyte transendothelial migration. Annual Review of Pathology 2011 6 323 344
73. Iigo Y., Suematsu M., Higashida T., Oheda J.-I., Matsumoto K., Wakabayashi Y., Ishimura Y., Miyasaka M., Takashi T., Constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. American Journal of Physiology 1997 273 1, part 2 H138 H147 2-s2.0-0030829292
74. Klein C. L., Bittinger F., Kohler H., Wagner M., Otto M., Hermanns I., Kirkpatrick C. J., Comparative studies on vascular endothelium in vitro: 3. Effects of cytokines on the expression of E-Selectin, ICAM-1 and VCAM-1 by cultured human endothelial cells obtained from different passages. Pathobiology 1995 63 2 83 92 2-s2.0-0029084945
75. Scholz D., Devaux B., Hirche A., Pötzsch B., Kropp B., Schaper W., Schaper J., Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell and Tissue Research 1996 284 3 415 423 2-s2.0-0029890129 10.1007/s004410050602
76. Hirashima Y., Nakamura S., Endo S., Kuwayama N., Naruse Y., Takaku A., Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochemical Research 1997 22 10 1249 1255 2-s2.0-0030804604 10.1023/A:1021985030331
77. Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Kreisel S., Brunner J., Schmiedek P., Hennerici M., Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. Journal of Neurology Neurosurgery and Psychiatry 2001 70 4 534 537 2-s2.0-0035056594 10.1136/jnnp.70.4.534
78. Muroi C., Burkhardt J. K., Hugelshofer M., Seule M., Mishima K., Keller E., Magnesium and the inflammatory response: potential pathophysiological implications in the management of patients with aneurysmal subarachnoid hemorrhage? Magnesium Research 2012 25 2 64 71
79. Ni W., Gu Y. X., Song D. L., Leng B., Li P. L., Mao Y., The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochirurgica. Supplement 2011 110 1 203 208 2-s2.0-79952278125
80. Hendryk S., Jarzab B., Josko J., Increase of the IL-1 β and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinology Letters 2004 25 1-2 141 147 2-s2.0-3242781843
81. Mathieson T., Edner G., Ulfarsson E., Andersson B., Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor- α following subarachnoid hemorrhage. Journal of Neurosurgery 1997 87 2 215 220 2-s2.0-0030833671
82. Sarrafzadeh A., Schlenk F., Gericke C., Vajkoczy P., Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocritical Care 2010 13 3 339 346 2-s2.0-78649709699 10.1007/s12028-010-9432-4
83. Rothoerl R. D., Axmann C., Pina A.-L., Woertgen C., Brawanski A., Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 2006 18 1 68 72 2-s2.0-33644874673 10.1097/01.ana.0000181693.30750.af
84. Parkinson D., Stephensen S., Leukocytosis and subarachnoid hemorrhage. Surgical Neurology 1984 21 2 132 134 2-s2.0-0021330928
85. Crompton M. R., The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964 87 3 491 510 2-s2.0-0000709704 10.1093/brain/87.3.491
86. Hughes J. T., Schianchi P. M., Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. Journal of Neurosurgery 1978 48 4 515 525 2-s2.0-0017808458
87. Fraticelli A. T., Cholley B. P., Losser M.-R., Maurice J.-P. S., Payen D., Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008 39 3 893 898 2-s2.0-41249084454 10.1161/STROKEAHA.107.492447
88. Biondi A., Ricciardi G. K., Puybasset L., Abdennour L., Longo M., Chiras J., Van Effenterre R., Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. American Journal of Neuroradiology 2004 25 6 1067 1076 2-s2.0-2942633719
89. Fathi A. R., Pluta R. M., Bakhtian K. D., Qi M., Lonser R. R., Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates: laboratory investigation. Journal of Neurosurgery 2011 115 6 1213 1220 2-s2.0-83055172318 10.3171/2011.7.JNS11390
90. Thampatty B. P., Sherwood P. R., Gallek M. J., Crago E. A., Ren D., Hricik A. J., Kuo C.-W. J., Klamerus M. M., Alexander S. A., Bender C. M., Hoffman L. A., Horowitz M. B., Kassam A. B., Poloyac S. M., Role of Endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocritical Care 2011 15 1 19 27 2-s2.0-80052611964 10.1007/s12028-011-9508-9
91. Asano T., Ikegaki I., Suzuki Y., Satoh S., Shibuya M., Endothelin and the production of cerebral vasospasm in dogs. Biochemical and Biophysical Research Communications 1989 159 3 1345 1351 2-s2.0-0024558112
92. Zimmermann M., Seifert V., Endothelin receptor antagonists and cerebral vasospasm. Clinical Autonomic Research 2004 14 3 143 145 2-s2.0-3242679437
93. Thorin E., Nguyen T.-D., Bouthillier A., Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke 1998 29 1 175 180 2-s2.0-0031963858
94. Bian K., Murad F., Nitric oxide (NO)-biogeneration, regulation, and relevence to human diseases. Frontiers in Bioscience 2003 8 d264 d278 2-s2.0-0038571272
95. Mascia L., Fedorko L., Stewart D. J., Mohamed F., TerBrugge K., Ranieri V. M., Wallace M. C., Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001 32 5 1185 1189 2-s2.0-0034839779
96. Kwan A.-L., Solenski N. J., Kassell N. F., Lee K. S., Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium. Acta Neurochirurgica 1997 139 3 240 248 2-s2.0-0030902691 10.1007/BF01844759
97. Pluta R. M., Thompson B. G., Dawson T. M., Snyder S. H., Boock R. J., Oldfield E. H., Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. Journal of Neurosurgery 1996 84 4 648 654 2-s2.0-0029995008
98. Iuliano B. A., Pluta R. M., Jung C., Oldfield E. H., Endothelial dysfunction in a primate model of cerebral vasospasm. Journal of Neurosurgery 2004 100 2 287 294 2-s2.0-0942287656
99. Pluta R. M., Afshar J. K. B., Boock R. J., Oldfield E. H., Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. Journal of Neurosurgery 1998 88 3 557 561 2-s2.0-0031891102
100. Peterson J. W., Nishizawa S., Hackett J. D., Bun T., Teramura A., Zervas N. T., Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990 21 1 133 137 2-s2.0-0025191287
101. Fei L., Golwa F., Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study. Clinical Drug Investigation 2007 27 12 827 832 2-s2.0-36348961838
102. Nagata K., Sasaki T., Iwama J., Mori T., Iwamoto S., Nirei H., Hamada K., Kirino T., Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model. Journal of Neurosurgery 1993 79 5 710 715 2-s2.0-0027382025
103. Minami N., Tani E., Yokota M., Maeda Y., Yamaura I., Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathologica 1991 81 4 401 407 2-s2.0-0025983426
104. Sugawara T., Ayer R., Jadhav V., Chen W., Tsubokawa T., Zhang J. H., Mechanisms of statin treatment in cerebral vasospasm. Acta neurochirurgica. Supplement 2011 110 2, part 2 9 11 2-s2.0-79952276806
105. Lynch J. R., Wang H., McGirt M. J., Floyd J., Friedman A. H., Coon A. L., Blessing R., Alexander M. J., Graffagnino C., Warner D. S., Laskowitz D. T., Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005 36 9 2024 2026 2-s2.0-24644488726 10.1161/01.STR.0000177879.11607.10
106. Trimble J. L., Kockler D. R., Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Annals of Pharmacotherapy 2007 41 12 2019 2023 2-s2.0-36849010581 10.1345/aph.1K301
107. Bowman G., Dixit S., Bonneau R. H., Chinchilli V. M., Cockroft K. M., Findlay J. M., Schackert G., Macdonald R. L., Connolly E. S. Jr., Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model. Neurosurgery 2004 54 3 719 726 2-s2.0-1542346492
108. Yahia A. M., Kirmani J. F., Qureshi A. I., Guterman L. R., Hopkins L. N., The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocritical Care 2005 3 1 16 23 2-s2.0-24644473051 10.1385/Neurocrit. Care2005;3:16-23
109. Shah Q. A., Memon M. Z., Suri M. F. K., Rodriguez G. J., Kozak O. S., Taylor R. A., Tummala R. P., Vazquez G., Georgiadis A. L., Qureshi A. I., Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocritical Care 2009 11 2 190 198 2-s2.0-70350569877 10.1007/s12028-009-9209-9
110. Pyne G. J., Cadoux-Hudson T. A. D., Clark J. F., Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. British Journal of Neurosurgery 2001 15 5 409 415 2-s2.0-0035489362 10.1080/ 02688690120082413
111. Mori K., Yamamoto T., Miyazaki M., Hara Y., Aiko Y., Koike N., Sakamoto S., Nakao Y., Esaki T., Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model. British Journal of Neurosurgery 2012 26 1 64 68 2-s2.0-84856611311 10.3109/02688697.2011.591948
112. Jeon J. S., Sheen S. H., Hwang G., Kang S. H., Heo D. H., Cho Y. J., Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Journal of Korean Neurosurgical Society 2012 52 2 75 79
113. Altura B. T., Altura B. M., Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neuroscience Letters 1980 20 3 323 327 2-s2.0-0019295343 10.1016/0304-3940(80) 90168-8
114. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology 2011 10 7 618 625 2-s2.0-79958803259 10.1016/S1474-4422(11)70108-9
115. Hong Y., Guo S., Chen S., Sun C., Zhang J., Sun X., Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Journal of Neuroscience Research 2012 90 8 1670 1680
116. Lim M., Bower R. S., Wang Y., Sims L., Bower M. R., Camara-Quintana J., Li G., Cheshier S., Harsh G. R. IV, Steinberg G. K., Guccione S., The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurgical Review 2012 35 3 413 419 2-s2.0-84857349019 10.1007/s10143-012-0375-4
117. Prokopowicz Z., Marcinkiewicz J., Katz D. R., Chain B. M., Neutrophil myeloperoxidase: soldier and statesman. Archivum Immunologiae et Therapiae Experimentalis 2012 60 1 43 54 2-s2.0-84858795011 10.1007/s00005-011-0156-8
118. Frontera J. A., Fernandez A., Schmidt J. M., Claassen J., Wartenberg K. E., Badjatia N., Connolly E. S., Mayer S. A., Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009 40 6 1963 1968 2-s2.0-66849135274 10.1161/STROKEAHA.108.544700
119. Meyers P. M., Connolly E. S. Jr., Stroke: disappointing results for clazosentan in CONSCIOUS-2. Nature Reviews Neurology 2011 7 12 660 661 2-s2.0-83055176515 10.1038/nrneurol.2011.168
120. Hansen-Schwartz J., Vajkoczy P., Macdonald R. L., Pluta R. M., Zhang J. H., Cerebral vasospasm: looking beyond vasoconstriction. Trends in Pharmacological Sciences 2007 28 6 252 256 2-s2.0-34249333412 10.1016/j.tips.2007.04.002
121. Leng L. Z., Fink M. E., Iadecola C., Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Archives of Neurology 2011 68 1 31 36 2-s2.0-78651280074 10.1001/archneurol. 2010.226
122. Muroi C., Seule M., Mishima K., Keller E., Novel treatments for vasospasm after subarachnoid hemorrhage. Current Opinion in Critical Care 2012 18 2 119 126 2-s2.0-84858794741 10.1097/MCC.0b013e32835075ae
123. Vergouwen M. D. I., Vermeulen M., Coert B. A., Stroes E. S. G., Roos Y. B. W. E. M., Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2008 28 11 1761 1770 2-s2.0-54949118311 10.1038/jcbfm.2008. 74
124. Rowland M. J., Hadjipavlou G., Kelly M., Westbrook J., Pattinson K. T., Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. British Journal of Anaesthesia 2012 109 3 315 329
125. Claassen J., Carhuapoma J. R., Kreiter K. T., Du E. Y., Connolly E. S., Mayer S. A., Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002 33 5 1225 1232 2-s2.0-0036094267 10.1161/01.STR.0000015624.29071.1F
126. Nornes H., The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. Journal of Neurosurgery 1973 39 2 226 234 2-s2.0-0015858693
127. Grote E., Hassler W., The critical first minutes after subarachnoid hemorrhage. Neurosurgery 1988 22 4 654 661 2-s2.0-0023925799
128. Rätsep T., Asser T., Cerebral hemodynamic impairment after aneurysmal subarachnoid hemorrhage as evaluated using transcranial Doppler ultrasonography: relationship to delayed cerebral ischemia and clinical outcome. Journal of Neurosurgery 2001 95 3 393 401 2-s2.0-0034864238
129. Dreier J. P., Woitzik J., Fabricius M., Bhatia R., Major S., Drenckhahn C., Lehmann T.-N., Sarrafzadeh A., Willumsen L., Hartings J. A., Sakowitz O. W., Seemann J. H., Thieme A., Lauritzen M., Strong A. J., Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006 129 12 3224 3237 2-s2.0-33845334199 10.1093/brain/awl297
130. Dreier J. P., Major S., Manning A., Woitzik J., Drenckhahn C., Steinbrink J., Tolias C., Oliveira-Ferreira A. I., Fabricius M., Hartings J. A., Vajkoczy P., Lauritzen M., Dirnagl U., Bohner G., Strong A. J., Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009 132 7 1866 1881 2-s2.0-67650089668 10.1093/brain/awp102
131. Frijns C. J. M., Fijnheer R., Algra A., Van Mourik J. A., Van Gijn J., Rinkel G. J. E., Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 1 77 83 2-s2.0-29644444287 10.1136/jnnp.2005.064956
132. Suzuki S., Kimura M., Souma M., Ohkima H., Iwabuchi T., Shimiz u T., Cerebral microthrombosis in symptomatic cerebral vasospasm-a quantitative histological study in autopsy cases. Neurologia Medico-Chirurgica 1990 30 5 309 316 2-s2.0-0025113021
133. Romano J. G., Forteza A. M., Concha M., Koch S., Heros R. C., Morcos J. J., Babikian V. L., Max Findlay J., Selman W. R., Loch Macdonald R., Barrow D. L., Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 2002 50 5 1026 1031 2-s2.0-0036590062 10.1097/00006123-200205000-00016
134. Al-Tamimi Y. Z., Bhargava D., Feltbower R. G., Hall G., Goddard A. J. P., Quinn A. C., Ross S. A., Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke 2012 43 3 677 682 2-s2.0-84857641353 10.1161/STROKEAHA.111. 625731
135. Bardutzky J., Witsch J., Jüttler E., Schwab S., Vajkoczy P., Wolf S., EARLYDRAIN-outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. Trials 2011 12, article 203 2-s2.0-80052831665 10.1186/1745-6215-12-203
136. Hänggi D., Eicker S., Beseoglu K., Behr J., Turowski B., Steiger H.-J., A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Zentralblatt fur Neurochirurgie 2009 70 2 61 67 2-s2.0-67649631567 10.1055/s-0028-1087214
137. Mathiesen T., Fuchs D., Wachter H., von Holst H., Increased CSF neopterin levels in subarachnoid hemorrhage. Journal of Neurosurgery 1990 73 1 69 71 2-s2.0-0025356790
138. Peterson J. W., Kwun B.-D., Hackett J. D., Zervas N. T., The role of inflammation in experimental cerebral vasospasm. Journal of Neurosurgery 1990 72 5 767 774 2-s2.0-0025238859
139. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T.-A., Takeuchi T., Inoue I., Takeda J., Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 1999 19 11 1279 1288 2-s2.0-0033510084
140. Aihara Y., Kasuya H., Onda H., Hori T., Takeda J., Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001 32 1 212 217 2-s2.0-0035155769
141. McGirt M. J., Lynch J. R., Blessing R., Warner D. S., Friedman A. H., Laskowitz D. T., Lawton M. T., Awad I. A., Max Findlay J., Friedlander R. M., Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002 51 5 1128 1135 2-s2.0-0036871423 10.1097/00006123-200211000-00005
142. Sasaki T., Kasuya H., Onda H., Sasahara A., Goto S., Hori T., Inoue I., Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage. Stroke 2004 35 6 1466 1470 2-s2.0-2542630627 10.1161/01.STR.0000127425.47266.20
143. Zhou M.-L., Shi J.-X., Hang C.-H., Cheng H.-L., Qi X.-P., Mao L., Chen K.-F., Yin H.-X., Potential contribution of nuclear factor- B to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Journal of Cerebral Blood Flow and Metabolism 2007 27 9 1583 1592 2-s2.0-34548131647 10.1038/sj.jcbfm.9600456
144. Wang Z., Wang K.-Y., Wu Y., Zhou P., Sun X.-O., Chen G., Potential role of CD34 in cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Cytokine 2010 52 3 245 251 2-s2.0-79953304551
145. Wirrig C., Hunter I., Mathieson F. A., Nixon G. F., Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. Journal of Cerebral Blood Flow & Metabolism 2011 31 1 212 221
146. Tokiyoshi K., Ohnishi T., Nii Y., Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surgical Neurology 1991 36 2 112 118 2-s2.0-0025768647 10.1016/0090-3019(91) 90228-2
147. Iseda K., Ono S., Onoda K., Satoh M., Manabe H., Nishiguchi M., Takahashi K., Tokunaga K., Sugiu K., Date I., Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. Journal of Neurosurgery 2007 107 1 128 135 2-s2.0-34347379089 10.3171/JNS-07/07/0128
148. Yoshimoto T., Shirasaka T., Fujimoto S., Yoshidumi T., Yamauchi T., Tokuda K., Kaneko S., Kashiwaba T., Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage. Neurologia Medico-Chirurgica 2009 49 6 235 240 2-s2.0-67650911927 10.2176/nmc.49.235
149. Wu Y., Zhao X.-D., Zhuang Z., Xue Y.-J., Cheng H.-L., Yin H.-X., Shi J.-X., Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells. Brain Research 2010 1322 102 108 2-s2.0-77649239163 10.1016/j.brainres.2010.01.073
150. Chang C.-Z., Lin C.-L., Kassel N. F., Kwan A.-L., Howng S.-L., 6-mercaptopurine attenuates adhesive molecules in experimental vasospasm. Acta Neurochirurgica 2010 152 5 861 867 2-s2.0-77953020143 10.1007/s00701-010-0602-0
151. Muehlschlegel S., Rordorf G., Sims J., Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke 2011 42 5 1301 1306 2-s2.0-79955477320 10.1161/STROKEAHA.110.603159
152. Zhang W., Khatibi N. H., Yamaguchi-Okada M., Yan J., Chen C., Hu Q., Meng H., Han H., Liu S., Zhou C., Mammalian target of rapamycin (mTOR) inhibition reduces cerebral vasospasm following a subarachnoid hemorrhage injury in canines. Experimental Neurology 2012 233 2 799 806 2-s2.0-84856555903 10.1016/j.expneurol.2011.11.046